Literature DB >> 27314557

Effects of type II collagen epitope carbamylation and citrullination in human leucocyte antigen (HLA)-DR4(+) monozygotic twins discordant for rheumatoid arthritis.

M De Santis1,2, A Ceribelli1, F Cavaciocchi1, E Generali1, M Massarotti1, N Isailovic1, C Crotti1, H U Scherer3, C Montecucco4, C Selmi1,2.   

Abstract

The aim of this study is to investigate the effect of the native, citrullinated or carbamylated type II human collagen T cell- and B cell-epitopes on the adaptive immune response in rheumatoid arthritis (RA). Peripheral blood T and B cells obtained from a human leucocyte D4-related (antigen DR4(-) HLA-DR4)(+) woman with early RA, her healthy monozygotic twin and an unrelated HLA-DR3(+) woman with early RA were analysed for activation (CD154/CD69), apoptosis (annexin/7-aminoactinomycin), cytokine production [interferon (IFN)γ/interleukin (IL)-17/IL-4/IL-10/IL-6] and functional phenotype (CD45Ra/CCR7) after stimulation with the collagen native T cell epitope (T261-273), the K264 carbamylated T cell epitope (carT261-273), the native B cell epitope (B359-369) or the R360 citrullinated B cell epitope (citB359-369), and the combinations of these. The T cell memory compartment was activated by T cell epitopes in both discordant DR4(+) twins, but not in the DR3(+) RA. The collagen-specific activation of CD4(+) T cells was induced with both the native and carbamylated T cell epitopes only in the RA twin. Both T cell epitopes also induced IL-17 production in the RA twin, but a greater IL-4 and IL-10 response in the healthy twin. The citrullinated B cell epitope, particularly when combined with the carbamylated T cell epitope, induced B cell activation and an increased IL-6/IL-10 ratio in the RA twin compared to a greater IL-10 production in the healthy twin. Our data suggest that circulating collagen-specific T and B cells are found in HLA-DR4(+) subjects, but only RA activated cells express co-stimulatory molecules and produce proinflammatory cytokines. Carbamylation and citrullination further modulate the activation and cytokine polarization of T and B cells.
© 2016 British Society for Immunology.

Entities:  

Keywords:  carbamylation; citrullination; rheumatoid arthritis; type II human collagen

Mesh:

Substances:

Year:  2016        PMID: 27314557      PMCID: PMC4991524          DOI: 10.1111/cei.12825

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  47 in total

1.  Criteria for environmentally associated autoimmune diseases.

Authors:  Frederick W Miller; K Michael Pollard; Christine G Parks; Dori R Germolec; Patrick S C Leung; Carlo Selmi; Michael C Humble; Noel R Rose
Journal:  J Autoimmun       Date:  2012-07-06       Impact factor: 7.094

Review 2.  Immunity to citrullinated proteins in rheumatoid arthritis.

Authors:  Lars Klareskog; Johan Rönnelid; Karin Lundberg; Leonid Padyukov; Lars Alfredsson
Journal:  Annu Rev Immunol       Date:  2008       Impact factor: 28.527

Review 3.  Use of gene-modified regulatory T-cells to control autoimmune and alloimmune pathology: is now the right time?

Authors:  Hannah Jethwa; Antonella A Adami; John Maher
Journal:  Clin Immunol       Date:  2013-11-16       Impact factor: 3.969

4.  Prediction of carbamylated lysine sites based on the one-class k-nearest neighbor method.

Authors:  Guohua Huang; You Zhou; Yuchao Zhang; Bi-Qing Li; Ning Zhang; Yu-Dong Cai
Journal:  Mol Biosyst       Date:  2013-11

Review 5.  Posttranslational protein modifications, apoptosis, and the bypass of tolerance to autoantigens.

Authors:  P J Utz; P Anderson
Journal:  Arthritis Rheum       Date:  1998-07

Review 6.  Interleukin-17 and innate immunity in infections and chronic inflammation.

Authors:  Natasa Isailovic; Kenji Daigo; Alberto Mantovani; Carlo Selmi
Journal:  J Autoimmun       Date:  2015-05-18       Impact factor: 7.094

Review 7.  Collagens: molecular biology, diseases, and potentials for therapy.

Authors:  D J Prockop; K I Kivirikko
Journal:  Annu Rev Biochem       Date:  1995       Impact factor: 23.643

8.  Familial aggregation of arthritis-related diseases in seropositive and seronegative rheumatoid arthritis: a register-based case-control study in Sweden.

Authors:  Thomas Frisell; Karin Hellgren; Lars Alfredsson; Soumya Raychaudhuri; Lars Klareskog; Johan Askling
Journal:  Ann Rheum Dis       Date:  2014-12-12       Impact factor: 19.103

9.  Antihomocitrullinated fibrinogen antibodies are specific to rheumatoid arthritis and frequently bind citrullinated proteins/peptides.

Authors:  Mathias Scinocca; David A Bell; Maud Racapé; Radha Joseph; Gary Shaw; John K McCormick; Dafna D Gladman; Janet Pope; Lillian Barra; Ewa Cairns
Journal:  J Rheumatol       Date:  2014-01-15       Impact factor: 4.666

Review 10.  Myeloperoxidase-mediated lipoprotein carbamylation as a mechanistic pathway for atherosclerotic vascular disease.

Authors:  Sanjeev Sirpal
Journal:  Clin Sci (Lond)       Date:  2009-05       Impact factor: 6.124

View more
  2 in total

1.  The long and latent road to autoimmunity.

Authors:  Carlo Selmi; M Eric Gershwin
Journal:  Cell Mol Immunol       Date:  2018-03-22       Impact factor: 11.530

2.  Lymphocyte modulation by tofacitinib in patients with rheumatoid arthritis.

Authors:  Natasa Isailovic; Angela Ceribelli; Gilberto Cincinelli; Matteo Vecellio; Giacomo Guidelli; Marta Caprioli; Nicoletta Luciano; Francesca Motta; Carlo Selmi; Maria De Santis
Journal:  Clin Exp Immunol       Date:  2021-05-28       Impact factor: 5.732

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.